The 2nd Annual meeting for the Cross-IMI AMR Accelerator community will take place on 28 September as a digital event. Registration for both main session and breakout sessions via the link provided by personal e-mail invitation only is required. Details about the programme can be found in the agenda below.  

The first part of this TB research focused webinar will introduce UNITE4TB, the newest member of the AMR Accelerator. The second part will discuss and address the challenges of the TB research community. We will discuss the fit of the current TB focused portfolio of projects with the global TB community and pipeline. Further activities […]

GNA NOW Open Call webinar II  In case you missed the first webinar on 12 May, this is your second chance to attend the GNA NOW Open Call webinar and ask questions to Project Lead Eric Bacqué of Evotec and Project Coordinator Kristina Orrling of Lygature. The GNA NOW Consortium is looking for a novel […]

  This webinar will cover the use of knowledge management tools in the IMI AMR Accelerator and how these can be used to both enhance data analysis workflows and also promote collaborations across projects and teams. To support these efforts the AMR Data Management group have developed a set of database and visualisation tools based […]

Join us for this online webinar on Wednesday 12 May and find out about a unique opportunity for the antibiotic community. The Innovative Medicines Initiative's GNA NOW Consortium is looking for a novel antibiotic compound to progress to a clinical candidate. To find out more about what the Consortium is looking for, what’s in it […]

The COMBINE project is part of the IMI AMR Accelerator. One of the scientific aims of COMBINE is to improve and standardize the pneumonia animal model used in AMR research and to develop improved tools to reliably translate results in animals into results in humans. Aim of the workshop: This workshop will address the need […]

December 3, 2020, 3.30PM-4.30PM CET Peter Warn is an experienced antimicrobial discovery scientist and consultant with a long and successful record of working in the anti-infective discovery industry. His expertise goes from antimicrobial development (antibacterial, anti-fungal, anti-parasitic and anti Mtb), including in vitro, and animal models from basic models through to PKPD and assisting in […]

This webinar will provide an overview of animal infection models commonly used for studies of antibiotics against gram-negative bacteria. The webinar is driven by the COMBINE objective to harmonize and standardize a protocol for a mouse infection model used for efficacy and PKPD studies. The infection model will be validated through well-characterized bacterial strains and […]